Experience Remission from Depression, with Spravato®

Spravato® is the first FDA approved prescription nasal spray for treatment-resistant depression, providing relief in as little as 24 hours.

What is Spravato®?

Spravato (esketamine) is a prescription nasal spray that is used to treat adults with treatment-resistant depression (TRD), or major depressive disorder with suicidal ideation.

Unlike oral antidepressants, Spravato is a novel mechanism that acts on different receptors (NMDA vs. serotonin receptors) to treat depression and bring fast relief.

FDA Approved

For adults struggling with

treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.

Sustainable Relief

About 70% of patients show a clinically meaningful response, with treatments easily integrated into your life.

Insurance Coverage

Spravato is covered by several major insurance payers, including Medicare and Medicaid, making it an accessible option for many if you've tried antidepressants and therapy.

Spravato® is taken at a REMS Certified Treatment Center

3 Treatment Phases

Induction: Twice weekly for the first 4 weeks

Maintenance: Once weekly for the following 4 weeks

After this 8-week treatment course, you will meet with your provider to discuss the best treatment cadence going forward..

Treatment Protocol

Following administration, you will be observed for 2 hours by your provider

Patient cannot drive from their appointment on treatment days due to side effects, find your ride!

We Accept Most Insurance Plans

Meet Our Chief Medical Officer

Dr. Pritham Raj is a board-certified expert in internal medicine and psychiatry, specializing in the connection between mental and physical health. He earned his medical degree from the University of Maryland and completed a combined residency at Duke University, where he contributed to early TMS research.

Dr. Raj’s research focuses on obesity, depression, and cognitive health. Passionate about wellness, he trained as a Chief Wellness Officer at Stanford University and has provided expert insights on the mental and physical impacts of the COVID-19 pandemic. Outside of work, he enjoys time with his children and leads DARK to Light, a nonprofit supporting children of separating families.

Locations in Oregon & Washington

Clackamas, OR

10151 SE Sunnyside Road, Suite #360,

Clackamas, OR, 97015

Portland, OR

2701 NW Vaughn St, Suite #470

Portland, OR, 97210

Salem, OR

2525 12th St SE, Suite #210,

Salem, OR, 97302

Tigard, OR

11850 SW 67th Avenue Suite 130

Portland, OR 97223

Kirkland, WA

4020 Lake Washington Blvd NE, Suite #210,

Kirkland, WA, 98033

Vancouver, WA

Columbia Tech Center, Building 608 1499 S.E. Tech Center Place, Suite #170,

Vancouver, WA, 98683

Ⓒ 2026 — https://activepath.com/ — All rights reserved

Contact Info

2701 NW Vaughn St #470, Portland, OR 97210

Business Hours

7:30 AM–6:30 PM

Ⓒ 2026 — https://activepath.com/ — All rights reserved